MENU
MLYS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mineralys Therapeutics (MLYS) Ownership - Who owns Mineralys Therapeutics?
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone... Show more
Profile
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
28
Web
https://mineralystx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
850.29M
P/E Ratio
N/A
Total Cash
198.19M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.16
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MLYS
Capitalization
850M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
198M
Total Cash/Share
3.16
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
191M
P/B Ratio
4.45
Cash Flow
N/A
Earnings
-3.66
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
14.02
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-192.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-77.72
Shares Held By Institutions
685M
Shares Outstanding - Current
62.8M
Total Liabilities
14.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
9.911
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
28
Web
https://mineralystx.com